Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Director's Dealing 2025

Dec 5, 2025

31041_dirs_2025-12-05_940f0161-4e78-4733-9bae-01559b03be66.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2025-12-04

Reporting Person: van Gunsteren Job Leonard (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-04 Common Stock M 6000 $60.85 Acquired 15446 Direct
2025-12-04 Common Stock S 4235 $153.0717 Disposed 11211 Direct
2025-12-04 Common Stock S 1765 $153.8039 Disposed 9446 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-04 Stock Option $60.85 M 6000 Acquired 2026-02-23 Common Stock (6000) Direct

Footnotes

F1: Exercise of fully vested non-qualified stock options.

F2: This transaction was executed in multiple sales ranging from $152.6500 to $153.6100 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

F3: This transaction was executed in multiple sales ranging from $153.6900 to $154.0600 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

F4: Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.